Financhill
Back

Kymera Therapeutics Vs. Vir Biotechnology Industry Stock Comparison

Sell
47

KYMR
Kymera Therapeutics

Last Price:
42.13
Seasonality Move:
17.88%
Sell
28

VIR
Vir Biotechnology

Last Price:
7.45
Seasonality Move:
40.33%
Sell
47
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $42.13. The Score for KYMR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Vir Biotechnology (VIR) is a Sell

Is Vir Biotechnology a Buy, Sell or Hold?

  • The current Vir Biotechnology [VIR] share price is $7.45. The Score for VIR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • VIR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $42.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight buying pressure.

VIR Stock Price Chart

What is Vir Biotechnology's stock price today?

  • The Vir Biotechnology share price today is $7.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VIR is experiencing slight buying pressure.

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.87 Sell
Relative Strength Index (14 RSI): 40.12 Sell
Chaikin Money Flow: 59591 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.06 - 48.4) Sell
Bollinger Bands (100): (43.26 - 48.72) Sell

VIR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 43.83 Sell
Chaikin Money Flow: 245829 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.21 - 8.91) Sell
Bollinger Bands (100): (7.33 - 9.11) Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.35 Sell
20-day SMA: 44.79 Sell
50-day SMA: 46.11 Sell
200-day SMA: 41.35 Buy
8-day EMA: 44.07 Sell
20-day EMA: 45.15 Sell
50-day EMA: 45.78 Sell
200-day EMA: 41.1 Buy

VIR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.03 Sell
20-day SMA: 7.76 Sell
50-day SMA: 8.02 Sell
200-day SMA: 9 Sell
8-day EMA: 7.87 Sell
20-day EMA: 8 Sell
50-day EMA: 8.08 Sell
200-day EMA: 9.21 Sell

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

Vir Biotechnology Earnings Growth & VIR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.07 per share.

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vir Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):